問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Cancer Center

Division of Ophthalmology

更新時間:2026-03-01

侯宜廷
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2026-01-27 - 2030-12-31

Phase II

Active
A Phase 2 Open-Label, Umbrella Platform Design Study of Investigational Agent(s) in Participants With 2L/3L Unresectable Locally Advanced or Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06F
  • Condition/Disease

    Oesophageal Squamous Cell Carcinoma

  • Test Drug

    ifinatamab deruxtecan (I-DXd)

Participate Sites
7Sites

Recruiting7Sites